Centrient Pharmaceuticals (@Centrient) header
Centrient Pharmaceuticals (@Centrient) profile picture

Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals.

Rotterdam, Netherlands
Joined January 2025
Effective September 1, 2025, Centrient has appointed Pierre-Yves Dalla-Libera as the new manufacturing Site Director for Delft.
1
1
89
Recently wrapped up a productive visit to Brussels, tackling one of Europe’s biggest health challenges: antibiotic supply. Centrient is ready to lead—with scale, expertise, and commitment to resilient manufacturing in Europe and we are proud to be part of the solution.
1
2
59
Effective Jan 2025, Centrient is proud to announce the appointment of Phil Wieland as the new Chairman of its Supervisory Board of Directors. Mr. Wieland will better position Centrient to continue delivering on its mission to provide sustainable solutions & life-saving medicines.
62
Centrient is proud to announce that, for the fifth year in a row, it has received a Gold sustainability rating from EcoVadis! The 2024 Gold rating ranks Centrient within the top 5% of all companies assessed by EcoVadis.
48